← All trials
NCT04430192
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 9, 2020
- Primary completion
- Jun 30, 2022
- Completion date
- Jun 30, 2023
- First posted
- Jun 12, 2020
- Last posted
- Jun 12, 2020
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Peter MacCallum Cancer CentreLead sponsor
- Peter MacCallum Cancer CentreOverall official - principal investigator
- EndocyteCollaborator
- Movember FoundationCollaborator
- E.J. Whitten Foundation Prostate Cancer Research CentreCollaborator
- Medical Research Future Fund (MRFF)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.